Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056434
Filing Date
2021-11-12
Accepted
2021-11-12 06:55:18
Documents
86
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q txmd-10q_20210930.htm   iXBRL 10-Q 2435267
2 EX-10.5 txmd-ex105_310.htm EX-10.5 21408
3 EX-31.1 txmd-ex311_6.htm EX-31.1 17707
4 EX-31.2 txmd-ex312_8.htm EX-31.2 17725
5 EX-32.1 txmd-ex321_9.htm EX-32.1 7923
6 EX-32.2 txmd-ex322_7.htm EX-32.2 7880
7 GRAPHIC gprpiqfusrm4000001.jpg GRAPHIC 4411
  Complete submission text file 0001564590-21-056434.txt   10029139

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA txmd-20210930.xsd EX-101.SCH 72372
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE txmd-20210930_cal.xml EX-101.CAL 55077
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE txmd-20210930_def.xml EX-101.DEF 222492
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20210930_lab.xml EX-101.LAB 453054
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20210930_pre.xml EX-101.PRE 381639
13 EXTRACTED XBRL INSTANCE DOCUMENT txmd-10q_20210930_htm.xml XML 2264762
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 211399426
SIC: 2834 Pharmaceutical Preparations